Figure 2.

Methylphenidate prescriptions trend in Germany, 1992 – 2005. Methylphenidate prescriptions grew 47-fold from 1992 to 2005. During the same period, total prescriptions in Germany declined by 41 percent. Data source: Wissenschaftliches Institut der AOK, Schwabe and Paffrath, 1993 – 2006 [20]; note change of database for year 2001/2002. All data refer to prescriptions reimbursed by statutory health insurance (SHI, "GKV", covering approximately 90 percent of German population); excluding parallel imports. Note that these data include prescriptions for adults with ADHD and also for other indications (narcolepsy).